Literature DB >> 16413031

Buffy coat preparation is a convenient source of progenitors for culturing mature human mast cells.

X S Wang1, K H Yip, S W Sam, H Y A Lau.   

Abstract

Mast cells are unique immune cells that release a spectrum of chemical mediators contributing to the inflammatory symptoms of allergic disorders. Mature mast cells have recently been cultured from CD34(+) progenitors isolated from fresh umbilical cord blood and adult peripheral blood. In the current study, we investigated whether buffy coat preparations, which are readily available from blood banks, could be used as a convenient and more abundant source of progenitors for culturing human mast cells. We were able to culture a homogeneous population of human mast cells from progenitor cells isolated from human buffy coat. Morphologically, our cultured mast cells contained abundant cytoplasmic granules which stained positively using antibodies against human mast cell tryptase and, to a lesser extent, with those against human mast cell chymase. Functionally, these cultured mast cells responded to anti-human-IgE by releasing histamine in a dose-dependent manner after sensitization with human IgE. Taken together, buffy coat preparations can be a convenient source for culturing human mast cells which are predominantly tryptase positive only and express functional high-affinity IgE receptors.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16413031     DOI: 10.1016/j.jim.2005.11.012

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  7 in total

1.  Reciprocal modulation of anti-IgE induced histamine release from human mast cells by A₁ and A(2B) adenosine receptors.

Authors:  K H Yip; H Y A Lau; H Wise
Journal:  Br J Pharmacol       Date:  2011-09       Impact factor: 8.739

2.  Novel six-week protocol for generating functional human connective tissue-type (MCTC) mast cells from buffy coats.

Authors:  Issan Yee San Tam; Chun Wai Ng; See-Ying Tam; Hang Yung Alaster Lau
Journal:  Inflamm Res       Date:  2016-09-15       Impact factor: 4.575

3.  Inhibition of anti-IgE mediated human mast cell activation by NO donors is dependent on their NO release kinetics.

Authors:  K H Yip; F P Leung; Y Huang; H Y A Lau
Journal:  Br J Pharmacol       Date:  2009-03-19       Impact factor: 8.739

4.  IL-4 amplifies the pro-inflammatory effect of adenosine in human mast cells by changing expression levels of adenosine receptors.

Authors:  Xiaoyang Hua; Kelly D Chason; Janki Y Patel; Warren C Naselsky; Stephen L Tilley
Journal:  PLoS One       Date:  2011-09-26       Impact factor: 3.240

5.  Aberrant splicing of the hRasGRP4 transcript and decreased levels of this signaling protein in the peripheral blood mononuclear cells in a subset of patients with rheumatoid arthritis.

Authors:  Toko Hashimoto; Shinsuke Yasuda; Hideyuki Koide; Hiroshi Kataoka; Tetsuya Horita; Tatsuya Atsumi; Takao Koike
Journal:  Arthritis Res Ther       Date:  2011-09-20       Impact factor: 5.156

6.  Immobilized Osteopontin Enhances Adhesion but Suppresses Cytokine Release of Anti-IgE Activated Human Mast Cells.

Authors:  Chun Wai Ng; Issan Yee San Tam; Sze Wing Sam; Yangyang Yu; Hang Yung Alaster Lau
Journal:  Front Immunol       Date:  2018-05-22       Impact factor: 7.561

7.  Clinical impact of real-time evaluation of the biological activity and degradation of hepatocyte growth factor.

Authors:  Fariba Nayeri; Tayeb Nayeri; Daniel Aili; Lars Brudin; Bo Liedberg
Journal:  Growth Factors       Date:  2008-06       Impact factor: 2.511

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.